Hofherr, Alexis
Williams, Julie
Gan, Li-Ming
Söderberg, Magnus
Hansen, Pernille B. L.
Woollard, Kevin J.
Funding for this research was provided by:
AstraZeneca
Article History
Received: 6 September 2021
Accepted: 20 April 2022
First Online: 13 June 2022
Declarations
:
: Not applicable.
: Not applicable.
: All authors are employees of AstraZeneca and own stock or stock options. AstraZeneca develops and markets treatments for kidney disease.